Verubecestat (MK-8931) Trifluoroacetate

製品コードS8173 バッチS817305

印刷

化学情報

Synonyms

MK-8931

Storage
(From the date of receipt)

3 years -20°C powder
1 years -80°C in solvent

化学式

C₁₉H₁₈F₅N₅O₅S

分子量

523.43

CAS No.

2095432-65-6

Solubility (25°C)*

体外

DMSO

100 mg/mL (191.04 mM)

Ethanol

15 mg/mL (28.65 mM)

Water

Insoluble

体内（毎回新しく調製した物を用意してください）

Clear solution

5%DMSO 1 Corn oil

5.0mg/ml

Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	Verubecestat (MK-8931) Trifluoroacetate is a potent and selective beta-secretase inhibitor and BACE1 protein inhibitor or Beta-site APP-cleaving enzyme 1 inhibitor.
in vitro	Verubecestat(MK-8931) effectively reduces Aβ40 in cells with a Ki of 7.8 nM and an IC50 of 13 nM^[2].
in vivo	Verubecestat(MK-8931) dramatically lowers CSF and cortex Aβ40 in both rats and cynomolgus monkeys following a single oral dose. Due to the 20 h half-life of MK-8931 it is ideal for once-a-day dosing^[2].

プロトコル(参考用のみ)

参考

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

A study of protein-drug interaction based on solvent-induced protein aggregation by fluorescence correlation spectroscopy [ Analyst, 2022, 10.1039/d2an00031h]	PubMed: 35253833
Improving Preclinical to Clinical Translation in Alzheimer's Disease Research [ Alzheimers Dement (N Y), 2020, 6(1):e12038]	PubMed: 32548237
Pharmacokinetic, Pharmacodynamics, and Transcriptomics Analysis of Verubecestat Treatment in 5XFAD mice [ Alzheimer's Association, 2020, 16-S2]	PubMed: None
Inhibition of BACE1 Facilitates Macrophage-based Immunotherapy to Suppress Malignant Growth of Glioblastoma [ Research Square, 2020, 10.21203/rs.3.rs-61939/v1]	PubMed: None
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression. [ Nat Commun, 2019, 10(1):2240]	PubMed: 31110178
Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life. [ Alzheimers Dement, 2019, 15(9):1183-1194]	PubMed: 31416794
Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. [ Am J Physiol Endocrinol Metab, 2019, 316(1):E106-E120]	PubMed: 30422705
Critical Evaluation of the Pharmacokinetics of Verubecestat in Aged 5XFAD Mice [ Alzheimer's Association, 2019, 15-7S-25]	PubMed: None
Distinct apoptotic blocks mediate resistance to panHER inhibitors in HER2+ breast cancer cells [Karakas B Biochim Biophys Acta Mol Cell Res, 2018, 1865(8):1073-1087]	PubMed: 29733883
HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. [ Nat Commun, 2017, 8(1):1522]	PubMed: 29142315

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。